The microsomal/peroxidase antigen: Modulation of its expression in thyroid cells

Luca Chiovato, Aldo Pinchera

Research output: Contribution to journalArticle

Abstract

Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular cAMP accumulation and protein synthesis. These data have been found true in any thyroid system studied so far, both in terms of immunologic and enzymatic activity of TPO. TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species. Whether this phenomenon is due to a direct transcriptional regulation of the TPO gene, as shown in dog thyroid cells, or to posttranscriptional effects, as it would appear in FRTL-5 cells, remains to be clarified by future experiments. Thyroid stimulating antibody (TSAb) of Graves' disease also stimulates the expression of M/TPO-Ag. This finding gives further support to the relevance of TSAb in the pathogenesis of hyperthyroidism and explains the well known observation that the "microsomal" antigen is particularly abundant in glands of Graves' patients. The modulation of M/TPO-Ag surface expression by TSH can explain the decrease of circulating anti-MAb observed during L-thyroxine therapy in hypothyroid patients with Hashimoto's thyroiditis. Other agents, such as methimazole and sodium iodide, which influence thyroid cell function, do not directly interfere with the expression of M/TPO-Ag. Cytokines, such as gamma-interferon, interleukin-1, and interleukin-6 have been shown to inhibit the TSH-induced increase of TPO mRNA, but further investigations are required to elucidate the exact role of cytokines in the regulation of M/TPO-Ag expression.

Original languageEnglish
Pages (from-to)319-331
Number of pages13
JournalAutoimmunity
Volume10
Issue number4
DOIs
Publication statusPublished - 1991

Fingerprint

Peroxidase
Thyroid Gland
Antigens
Thyroid-Stimulating Immunoglobulins
Sodium Iodide
Cytokines
Methimazole
Hashimoto Disease
Messenger RNA
Graves Disease
Hyperthyroidism
Thyroxine
Interleukin-1
Interferon-gamma
Interleukin-6
Observation
Dogs
Genes
Proteins
Therapeutics

Keywords

  • Microsomal/peroxidase antigen
  • Modulation of M/TPO-Ag by TSH and TSAb
  • Thyroid stimulating antibody (TSAb)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The microsomal/peroxidase antigen : Modulation of its expression in thyroid cells. / Chiovato, Luca; Pinchera, Aldo.

In: Autoimmunity, Vol. 10, No. 4, 1991, p. 319-331.

Research output: Contribution to journalArticle

@article{4b7bc354635147d1ae3d7f1f8083eca3,
title = "The microsomal/peroxidase antigen: Modulation of its expression in thyroid cells",
abstract = "Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular cAMP accumulation and protein synthesis. These data have been found true in any thyroid system studied so far, both in terms of immunologic and enzymatic activity of TPO. TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species. Whether this phenomenon is due to a direct transcriptional regulation of the TPO gene, as shown in dog thyroid cells, or to posttranscriptional effects, as it would appear in FRTL-5 cells, remains to be clarified by future experiments. Thyroid stimulating antibody (TSAb) of Graves' disease also stimulates the expression of M/TPO-Ag. This finding gives further support to the relevance of TSAb in the pathogenesis of hyperthyroidism and explains the well known observation that the {"}microsomal{"} antigen is particularly abundant in glands of Graves' patients. The modulation of M/TPO-Ag surface expression by TSH can explain the decrease of circulating anti-MAb observed during L-thyroxine therapy in hypothyroid patients with Hashimoto's thyroiditis. Other agents, such as methimazole and sodium iodide, which influence thyroid cell function, do not directly interfere with the expression of M/TPO-Ag. Cytokines, such as gamma-interferon, interleukin-1, and interleukin-6 have been shown to inhibit the TSH-induced increase of TPO mRNA, but further investigations are required to elucidate the exact role of cytokines in the regulation of M/TPO-Ag expression.",
keywords = "Microsomal/peroxidase antigen, Modulation of M/TPO-Ag by TSH and TSAb, Thyroid stimulating antibody (TSAb)",
author = "Luca Chiovato and Aldo Pinchera",
year = "1991",
doi = "10.3109/08916939109001906",
language = "English",
volume = "10",
pages = "319--331",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The microsomal/peroxidase antigen

T2 - Modulation of its expression in thyroid cells

AU - Chiovato, Luca

AU - Pinchera, Aldo

PY - 1991

Y1 - 1991

N2 - Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular cAMP accumulation and protein synthesis. These data have been found true in any thyroid system studied so far, both in terms of immunologic and enzymatic activity of TPO. TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species. Whether this phenomenon is due to a direct transcriptional regulation of the TPO gene, as shown in dog thyroid cells, or to posttranscriptional effects, as it would appear in FRTL-5 cells, remains to be clarified by future experiments. Thyroid stimulating antibody (TSAb) of Graves' disease also stimulates the expression of M/TPO-Ag. This finding gives further support to the relevance of TSAb in the pathogenesis of hyperthyroidism and explains the well known observation that the "microsomal" antigen is particularly abundant in glands of Graves' patients. The modulation of M/TPO-Ag surface expression by TSH can explain the decrease of circulating anti-MAb observed during L-thyroxine therapy in hypothyroid patients with Hashimoto's thyroiditis. Other agents, such as methimazole and sodium iodide, which influence thyroid cell function, do not directly interfere with the expression of M/TPO-Ag. Cytokines, such as gamma-interferon, interleukin-1, and interleukin-6 have been shown to inhibit the TSH-induced increase of TPO mRNA, but further investigations are required to elucidate the exact role of cytokines in the regulation of M/TPO-Ag expression.

AB - Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular cAMP accumulation and protein synthesis. These data have been found true in any thyroid system studied so far, both in terms of immunologic and enzymatic activity of TPO. TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species. Whether this phenomenon is due to a direct transcriptional regulation of the TPO gene, as shown in dog thyroid cells, or to posttranscriptional effects, as it would appear in FRTL-5 cells, remains to be clarified by future experiments. Thyroid stimulating antibody (TSAb) of Graves' disease also stimulates the expression of M/TPO-Ag. This finding gives further support to the relevance of TSAb in the pathogenesis of hyperthyroidism and explains the well known observation that the "microsomal" antigen is particularly abundant in glands of Graves' patients. The modulation of M/TPO-Ag surface expression by TSH can explain the decrease of circulating anti-MAb observed during L-thyroxine therapy in hypothyroid patients with Hashimoto's thyroiditis. Other agents, such as methimazole and sodium iodide, which influence thyroid cell function, do not directly interfere with the expression of M/TPO-Ag. Cytokines, such as gamma-interferon, interleukin-1, and interleukin-6 have been shown to inhibit the TSH-induced increase of TPO mRNA, but further investigations are required to elucidate the exact role of cytokines in the regulation of M/TPO-Ag expression.

KW - Microsomal/peroxidase antigen

KW - Modulation of M/TPO-Ag by TSH and TSAb

KW - Thyroid stimulating antibody (TSAb)

UR - http://www.scopus.com/inward/record.url?scp=0026094121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026094121&partnerID=8YFLogxK

U2 - 10.3109/08916939109001906

DO - 10.3109/08916939109001906

M3 - Article

C2 - 1663395

AN - SCOPUS:0026094121

VL - 10

SP - 319

EP - 331

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 4

ER -